The Davos of Precision Medicine. Driving the future of patient care.
Next-Gen Therapeutics
Cell therapy, targeted oncology, and programmable medicines, with the hard questions left in.
See the full Track 1 agenda → Swipe to see all three daysEngineered Cell & Gene Therapy Platforms
Off-the-shelf cells, AI-enabled design, in vivo delivery, manufacturing, and the solid-tumor challenge.
Katy Rezvani, MD Anderson
Antoni Ribas, UCLA
Immunotherapies & Targeted Therapies
Checkpoint failure, decision-grade biomarkers, resistance biology, adaptive combinations, and rare cancers.
Antoni Ribas, UCLA
Gerold Meinhardt, Daiichi Sankyo
Programmable Genetic Medicines
CRISPR, base and prime editing, programmable RNA, protein fate, and the delivery layer that decides what reaches patients.
Emmanuelle Charpentier ★, Max Planck
Randy Schekman ★, UC Berkeley
AI and Computational Medicine
Clinical AI, AI in diagnostics, and AI in drug discovery, with real builders and health-system leaders on stage.
See the full Track 2 agenda → Swipe to see all three daysMultimodal AI in Diagnostics
Computational pathology, omics foundation models, companion diagnostics, and what is ready for clinical use.
Fei-Fei Li, Stanford
Andrew Ng, DeepLearning.AI
Clinical AI: Deployment, Decision Support & RWE
AI agents, foundation models, safety, trials, and the realities of putting clinical AI into production.
Ziad Obermeyer, Dandelion Health
John Halamka, Mayo Clinic
AI in Drug Discovery & Computational Biology
Causal targets, proprietary data, designed proteins, smarter trials, and what survives contact with drug development.
David Baker ★, U. Washington
Daphne Koller, insitro
Precision Diagnostics
Blood-based and multimodal diagnostics from screening and interception to MRD, therapy guidance, and organ health.
See the full Track 3 agenda → Swipe to see all three daysFrom Screening to Interception
Risk-stratified screening, early detection, pre-cancer, multimodal signals, and the path from detection to action.
Mary-Claire King, U. Washington
Rebecca Fitzgerald, Cambridge
Liquid Biopsy: Therapy Guidance & Monitoring
MRD, response, resistance, therapy selection, multimodal monitoring, and evidence strong enough to change care.
Maximilian Diehn, Stanford
Sarah-Jane Dawson, U. Melbourne
Blood-Based Diagnostics Beyond Cancer
Transplant and organ health, infection, maternal-fetal health, and what it takes to reach standard of care.
Joseph DeRisi, UCSF
Alexandre Loupy, APHP / Inserm
Integrated Precision Medicine
Genomic diagnosis, population screening, implementation, prevention, and healthspan from discovery to operating model.
See the full Track 4 agenda → Swipe to see all three daysFrom Genomic Diagnosis to the Human Phenome
Rare-disease diagnosis, population screening, long reads, phenomics, and the next layer beyond the exome.
Wendy Chung, Harvard
Eric Lander, Broad
Integration & Implementation
Operating models, coverage, decision support, evidence, and the health-system work required to scale precision medicine.
Victor Dzau, NAM
Hal Paz, Khosla Ventures
Precision Aging, Prevention & Healthspan
Aging biology, GLP-1 and metabolism, biomarkers, wearables, prevention, and credible clinical translation.
Daniel Drucker, Sinai Health
Andrea Maier, NUS
Spatial & Translational Disease Biology
Spatial biology, precision immunology, and precision neurology translating tissue, immune, and brain signals into actionable care.
See the full Track 5 agenda → Swipe to see all three daysSpatial Biology & Tissue Architecture
Cell atlases, tissue architecture, spatial proteomics, AI, pathology, and reproducible clinical translation.
Sarah Teichmann, Cambridge
Aviv Regev, Genentech
Precision Immunology
Immune reset, tolerance, biomarkers, macrophage biology, inflammation, and better clinical-development strategies.
Miriam Merad, Mount Sinai
Jeffrey Bluestone, UCSF
Precision Neurology & Brain Health
Blood tests, imaging, neurodegeneration, brain rhythms, and the infrastructure needed to make precision neurology scale.
Thomas Südhof ★, Stanford
Li-Huei Tsai, MIT
Meet the leaders joining PMWC 2027
Nobel laureates, scientific pioneers, clinicians, builders, and health-system leaders rotate through this original-style PMWC speaker spotlight.
Speaker confirmation · PMWC 2027
Daniel Drucker joins PMWC 2027Breakthrough Prize-winning GLP-1 biology pioneer
Drucker helped define incretin biology and GLP-1 therapeutics, connecting obesity, diabetes, metabolic disease, and precision medicine.
Co-hosts
UCSF
University of Michigan
Duke
Yale Cancer Center
University of Pittsburgh
Stanford Health Care and Stanford Medicine
JOHN J SNINSKY – MOLECULAR STETHOSCOPE
PMWC provides a different type of meeting than nearly all others. The breadth and depth of information and selected timely topics focused on Precision Medicine combined with succinct presentations with commercial perspective is unique.
BROOK BYERS – PRECISION MEDICINE PIONEER
PMWC is one of the best conferences I’ve attended in MANY, MANY years.
PMWC is the Davos of Biotech
Congratulations on another super successful conference. What you have created is a unique format that allows for easy face to face meetings, even with legends in the hall coming off the stage. I love it.▶Watch Testimonial Video
LEE HOOD – PHENOME HEALTH
PMWC has proven, time and time again, that it attracts thought-leaders from all the relevant fields and catalyzes crucial collaboration through inspiring and practical program content.
Jensen Huang, CEO of NVIDIA, on the PMWC stage
PMWC brings leaders from technology, biology, healthcare, and industry into the same room. Watch Jensen Huang’s PMWC stage moment on AI, computing, and the future of medicine.
Take the stage in front of the people who can move the work forward.
Present a novel product or service, late-breaking research data, or an innovative project to a focused PMWC audience of scientific leaders, potential partners, investors, and clients.

Turn 3,000 attendees into the meetings that matter.
PMWC Connect helps you discover the right speakers, companies, investors, buyers, and collaborators—and then move from a useful match to an actual 1-to-1 meeting.
Partnering Lounge · Table 14
Be where the next precision-medicine decisions get made.
Three days of science, clinical translation, AI, diagnostics, therapeutics, and the conversations that happen between sessions—not months later.